3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
2
Conditions
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Neoplasms
1
Hodgkin Disease
1
Interventions
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
X-Rays
5
Phantoms, Imaging
5
Filgrastim
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Gemcitabine
4
Biopsy
4
tazemetostat
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Etoposide
3
Drug Therapy
3
Carboplatin
3
Busulfan
3
Bevacizumab
3
ulixertinib
2
tipifarnib
2
spartalizumab
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ganitumab
2
ensartinib
2
aflibercept
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Sarcoma
×
Triptorelin Pamoate
×
Lymphoid
×
Clear all
NCT05328258
2023-10-27
ProFertil
Karolinska University Hospital
Phase 3
Recruiting
500 enrolled
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled